These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 85461)

  • 1. Maternal serum alpha-fetoprotein screening in a provincial Health District.
    Woolfson J; Holt EM; Whyman AE; Mabbs DV
    Br J Obstet Gynaecol; 1979 Feb; 86(2):87-90. PubMed ID: 85461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal screening in Oxford for fetal neural tube defects.
    Wald NJ; Cuckle HS; Boreham J; Brett R; Stirrat GM; Bennett MJ; Turnbull AC; Solymar M; Jones N; Bobrow M; Evans CJ
    Br J Obstet Gynaecol; 1979 Feb; 86(2):91-100. PubMed ID: 85462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is maternal alpha-fetoprotein screening still of value in a low-risk area for neural tube defects?
    Hooker JG; Lucas M; Richards BA; Shirley IM; Thompson BD; Ward RH
    Prenat Diagn; 1984; 4(1):29-33. PubMed ID: 6203108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal alpha-fetoprotein screening: two years' experience in a low-risk district.
    Standing SJ; Brindle MJ; Macdonald AP; Lacey RW
    Br Med J (Clin Res Ed); 1981 Sep; 283(6293):705-7. PubMed ID: 6169386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal plasma alpha-fetoprotein screening for fetal neural tube defects.
    Brock DJ; Scrimgeour JB; Steven J; Barron L; Watt M
    Br J Obstet Gynaecol; 1978 Aug; 85(8):575-81. PubMed ID: 80224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum alpha-fetoprotein screening: a cost-benefit analysis.
    Layde PM; von Allmen SD; Oakley GP
    Am J Public Health; 1979 Jun; 69(6):566-73. PubMed ID: 87134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
    Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
    Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum alpha-fetoprotein screening in North Carolina: experience with more than twelve thousand pregnancies.
    Burton BK; Sowers SG; Nelson LH
    Am J Obstet Gynecol; 1983 Jun; 146(4):439-44. PubMed ID: 6190401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
    Crandall BF; Robertson RD; Lebherz TB; King W; Schroth PC
    West J Med; 1983 Apr; 138(4):524-30. PubMed ID: 6191442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
    Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
    Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum alpha-fetoprotein screening: promise not yet fulfilled.
    Nadler HL; Simpson JL
    Am J Obstet Gynecol; 1979 Sep; 135(1):1-2. PubMed ID: 89812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum alpha-fetoprotein screening in Natal. Results of over 12 000 tests.
    Grace HJ; Hitzeroth HW; Op't Hof J
    S Afr Med J; 1984 Jan; 65(1):8-11. PubMed ID: 6198731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis, fetal surgery, recurrence risk and differential diagnosis of neural tube defects.
    Chen CP
    Taiwan J Obstet Gynecol; 2008 Sep; 47(3):283-90. PubMed ID: 18935990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of maternal serum alpha-fetoprotein screening on antenatal diagnosis.
    Brock DJ
    Br Med J (Clin Res Ed); 1982 Jul; 285(6338):365-7. PubMed ID: 6178461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of pregnancy outcome after amniocentesis for previous neural tube defect or raised maternal serum alphafetoprotein.
    Read AP; Donnai D; Harris R; Donnai P
    Br J Obstet Gynaecol; 1980 May; 87(5):372-6. PubMed ID: 6155932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha-1-fetoprotein screening--development and problems].
    Grob PJ
    Soz Praventivmed; 1981 Sep; 26(4):217-20. PubMed ID: 6171116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic use of meternal serum alpha-fetoprotein levels.
    Cowchock FS; Jackson LG
    Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the value of measuring maternal serum alpha-fetoprotein for the antenatal diagnosis of neural tube defects.
    Tidy J
    Arch Gynecol Obstet; 1989; 244(3):133-6. PubMed ID: 2472120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.